Dr. Amatruda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15 West 81 Steeet
New York, NY 10024Phone+1 917-930-4796Fax+1 212-362-6726
Education & Training
- Johns Hopkins UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1973 - 1975
- Johns Hopkins UniversityResidency, Internal Medicine, 1970 - 1975
- Medical College of WisconsinClass of 1970
Certifications & Licensure
- NY State Medical License 1977 - 2026
- CT State Medical License 1992 - 2009
- MD State Medical License 1974 - 1978
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1982
Publications & Presentations
PubMed
- 38 citationsEfficacy and safety of sitagliptin added to ongoing metformin and rosiglitazone combination therapy in a randomized placebo-controlled 54-week trial in patients with t...Adrian S. Dobs, Barry J. Goldstein, Pablo Aschner, Edward S. Horton, Guillermo E. Umpierrez
Journal of Diabetes. 2013-03-01 - 18 citationsSitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetesAtsunori Kashiwagi, Takashi Kadowaki, Naoko Tajima, Kenji Nonaka, Tadaaki Taniguchi
Journal of Diabetes Investigation. 2011-10-01 - 104 citationsEfficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trialNir Barzilai, Hua Guo, Erin Mahoney, Suzanne Caporossi, Gregory T. Golm
Current Medical Research and Opinion. 2011-04-14
Press Mentions
- Why Are We Still so Fat?November 19th, 2018
- Boston Therapeutics Creates New Scientific Advisory BoardMarch 27th, 2018
Grant Support
- Metabolic Rate And Protein Turnover In ObesityNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1996
- Metabolic Rate And Protein Turnover In ObesityNational Center For Research Resources1992–1993
- Insulin Action In The LiverNational Institute Of Diabetes And Digestive And Kidney Diseases1988–1992
- Metabolic Rate And Protein Turnover In ObesityNational Institute Of Diabetes And Digestive And Kidney Diseases1989–1991
- Metabotic Rate And Protein Turnover In ObesityNational Center For Research Resources1990
- Insulin Binding Action And DegradationNational Institute Of Diabetes And Digestive And Kidney Diseases1986
- Protein Sparing FAST In The Treatment Of Simple ObesityNational Center For Research Resources1985
- Protein Fasts In Treatment Of Obesity And Type II Diabetes MellitusNational Center For Research Resources1985
- Insulin Binding Action And DegradationNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: